Mouse Anti-Human CD23-PE

Cat# 9580-09S

Size : 25tests

Brand : Southern Biotech

Contact local distributor :


Phone : +1 850 650 7790

More Information
Clone Tü1
Isotype Mouse IgG3κ
Isotype Control Mouse IgG3-PE (B10)
Specificity Human CD23
Alternative Names FCεRII, B6, Leu-20, BLAST-2, low affinity IgE receptor
Description CD23 is a 45 kDa type II integral membrane glycoprotein that is the low affinity receptor for IgE. It also binds to CD21 and the α chains of CD11b and CD11c. It is expressed by B cells and monocytes and, weakly, on T cells, follicular dendritic cells, eosinophils, NK cells, Langerhans cells, and platelets. It is upregulated in response to B cell activation, CD40 ligation, or in response to IL-4 or IL-13. CD23 is responsible for regulation of IgE synthesis and may play a role in antigen presentation by B cells and follicular dendritic cells by interacting with CD40.
Immunogen KR3598 cells
Conjugate PE (R-phycoerythrin)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration Lot specific
Volume 0.25 mL or 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Applications Flow Cytometry – Quality tested 2-5
Immunohistochemistry-Frozen Sections – Reported in literature 1,6,7
Immunocytochemistry – Reported in literature 7,8
Western Blot – Reported in literature 7,9,10
Blocking – Reported in literature 7

RRID Number AB_2796974
Gene ID 2208 (Human)
Gene ID Symbol FCER2 (Human)
Gene ID Aliases BLAST-2; CD23; CD23A; CLEC4J; FCE2; IGEBF
UniProt ID P06734 (Human
UniProt Name FCER2_HUMAN (Human)
Documentation
Technical Bulletin Safety Datasheet

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

  1. 1. Ziegler A, Stein H, Müller C, Wernet P. Tü1: a monoclonal antibody defining a B cell subpopulation - usefulness for the classificaton of non-Hodgkin's lymphomas. In: Knapp W, editor. Leukemia Markers: Proceedings of the Leukemia Marker Conference held in Vienna, February 15-18, 1981. London: Academic Press; 1981. p. 113-6. (Immunogen, IHC-FS)
  2. 2. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400. (FC)
  3. 3. Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303-8. (FC)
  4. 4. Johnson SE, Shah N, Panoskaltsis-Mortari A, LeBien TW. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J Immunol. 2005;175:7325-31. (FC)
  5. 5. Vaisitti T, Gaudino F, Ouk S, Moscvin M, Vitale N, Serra S, et al. Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor. Haematologica. 2017;102:1878-89. (FC)
  6. 6. Hermes B, Worm M, Nowak F, Kroczek RA, Stein H, Henz BM. Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. Acta Derm Venereol. 1997;77:441-5. (IHC-FS)
  7. 7. Tu Y, Salim S, Bourgeois J, Di Leo V, Irvine EJ, Marshall JK, et al. CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding. Gastroenterology. 2005;129:928-40. (IHC-FS, ICC, WB, Block)
  8. 8. Mason DY, Comans-Bitter WM, Cordell JL, Verhoeven MJ, van Dongen JJ. Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol. 1990;136:1215-22. (ICC)
  9. 9. Tu Y, Perdue MH. CD23-mediated transport of IgE/immune complexes across human intestinal epithelium: role of p38 MAPK. Am J Physiol Gastrointest Liver Physiol. 2006;291:G532-8. (WB)
  10. 10. Tu Y, Oluwole C, Struiksma S, Perdue MH, Yang PC. Mast cells modulate transport of CD23/IgE/antigen complex across human intestinal epithelial barrier. N Am J Med Sci. 2009;1:16-24. (WB)